928 Stock Overview
An investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
King International Investment Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.058 |
| 52 Week High | HK$0.13 |
| 52 Week Low | HK$0.041 |
| Beta | 0.10 |
| 11 Month Change | -7.94% |
| 3 Month Change | -27.50% |
| 1 Year Change | 31.82% |
| 33 Year Change | -50.00% |
| 5 Year Change | -61.33% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 928 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 9.4% | 0.9% | -0.02% |
| 1Y | 31.8% | -35.4% | -5.2% |
Return vs Industry: 928 exceeded the Hong Kong Healthcare industry which returned -35.4% over the past year.
Return vs Market: 928 exceeded the Hong Kong Market which returned -5.2% over the past year.
Price Volatility
| 928 volatility | |
|---|---|
| 928 Average Weekly Movement | 11.1% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in HK Market | 13.8% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 928's share price has been volatile over the past 3 months.
Volatility Over Time: 928's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 31 | Mingqing Liu | www.kinginternational.hk |
King International Investment Limited, an investment holding company, provides genetic testing and health data analysis services in the People’s Republic of China and Hong Kong. The company operates through two segments, Healthcare Products and Services Business, and Money Lending Business. The company also engages in money lending activities.
King International Investment Limited Fundamentals Summary
| 928 fundamental statistics | |
|---|---|
| Market cap | HK$107.32m |
| Earnings (TTM) | HK$15.82m |
| Revenue (TTM) | HK$233.68m |
6.8x
P/E Ratio0.5x
P/S RatioIs 928 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 928 income statement (TTM) | |
|---|---|
| Revenue | HK$233.68m |
| Cost of Revenue | HK$195.89m |
| Gross Profit | HK$37.79m |
| Other Expenses | HK$21.97m |
| Earnings | HK$15.82m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0085 |
| Gross Margin | 16.17% |
| Net Profit Margin | 6.77% |
| Debt/Equity Ratio | 0.9% |
How did 928 perform over the long term?
See historical performance and comparison